MarketCap
Aldeyra Therapeutics ALDX
€ 0.59
1.56%
Facebook
X
Telegram
Aldeyra Therapeutics ROA | ALDX
ROA Jährlich Aldeyra Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46.97 | -53.39 | -25.31 | -34.21 | -24.78 | -45.05 | -80.55 | -40.9 | -50.57 | -74.24 | -42.87 | -59.03 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -24.78 | -80.55 | -48.16 |
ROA Vierteljährlich Aldeyra Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34.3 | -35.51 | -35.54 | -41.0 | -47.15 | -50.14 | -52.02 | -47.08 | -35.17 | -27.85 | -20.26 | -23.82 | -27.73 | -29.85 | -32.92 | -31.17 | -30.81 | -29.53 | -26.51 | -26.64 | -33.43 | -37.08 | -41.76 | -49.75 | -53.63 | -67.75 | -75.3 | -77.37 | -71.13 | -76.08 | -78.94 | -81.8 | -86.36 | -67.37 | -66.52 | -62.08 | -64.8 | -71.03 | -64.06 | -69.1 | -66.08 | -60.46 | -53.96 | -46.18 | -58.56 | -67.23 | -105.79 | -92.84 | 183.67 | 161.17 | 555.23 | 555.69 | 248.69 | -41.91 | 348.91 | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 555.69 | -105.79 | -9.45 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Soligenix
SNGX
|
-120.19 | $ 0.32 | 0.37 % | $ 1.66 M |  USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
3.46 | $ 43.19 | 1.85 % | $ 49.5 B |  Israel |
 |
China SXT Pharmaceuticals
SXTC
|
-17.85 | $ 2.96 | 2.78 % | $ 2.01 M |  China |
 |
Spruce Biosciences
SPRB
|
-73.49 | $ 46.52 | -0.32 % | $ 35.7 M | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
0.76 | $ 20.83 | -0.38 % | $ 32.9 B |  Japan |
 |
Supernus Pharmaceuticals
SUPN
|
-2.66 | $ 29.29 | 1.88 % | $ 1.65 B | USA |
 |
Galapagos NV
GLPG
|
9.42 | - | - | $ 1.83 B |  Belgium |
 |
Savara
SVRA
|
-46.89 | $ 5.03 | 2.24 % | $ 1.12 B | USA |
 |
Teligent, Inc.
TLGT
|
-12.14 | - | -13.85 % | $ 16.1 M | USA |
 |
Viela Bio, Inc.
VIE
|
-35.6 | - | - | $ 2.91 B | USA |
 |
TG Therapeutics
TGTX
|
42.06 | $ 65.76 | 2.33 % | $ 9.49 B | USA |
 |
Aphria Inc.
APHA
|
-3.39 | - | -0.45 % | $ 4.87 B |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
-9.61 | - | -0.90 % | $ 104 M | USA |
 |
Chiasma, Inc.
CHMA
|
-42.41 | - | -6.00 % | $ 238 M | USA |
 |
Trevi Therapeutics
TRVI
|
-22.11 | $ 14.83 | -0.57 % | $ 2 B | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
-47.82 | - | - | $ 376 M | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
78.84 | - | 0.38 % | $ 12.9 M | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
-252799694827.9 | - | 2.07 % | $ 34.4 M | USA |
 |
Cerecor Inc.
CERC
|
-145.12 | - | -1.68 % | $ 283 M | USA |
 |
Constellation Pharmaceuticals, Inc.
CNST
|
-28.6 | - | - | $ 1.63 B | USA |
 |
Auris Medical Holding Ltd.
EARS
|
-39.43 | - | -1.77 % | $ 39.2 M |  Bermuda |
 |
Dicerna Pharmaceuticals, Inc.
DRNA
|
-15.93 | - | 0.34 % | $ 2.98 B | USA |
 |
ERYTECH Pharma S.A.
ERYP
|
-0.5 | - | 1.3 % | $ 27.7 M |  France |
 |
GW Pharmaceuticals plc
GWPH
|
-6.19 | - | - | $ 6.81 B |  Britain |
 |
Kadmon Holdings, Inc.
KDMN
|
-66.94 | - | - | $ 1.7 B | USA |
 |
Liminal BioSciences
LMNL
|
1.23 | - | - | $ 256 M | Canada |
 |
argenx SE
ARGX
|
14.88 | $ 977.91 | 0.65 % | $ 59.9 B |  Niderland |
 |
XBiotech
XBIT
|
-30.34 | $ 1.95 | -1.02 % | $ 59.5 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
-18.6 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
-75.26 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
-76.99 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
-21.46 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-16722.69 | - | - | $ 1.77 B | USA |
 |
Xenetic Biosciences
XBIO
|
-32.05 | $ 1.87 | 3.68 % | $ 3.18 M | USA |
 |
Viridian Therapeutics
VRDN
|
-38.09 | $ 31.22 | 1.17 % | $ 3.18 B | USA |
 |
Translate Bio, Inc.
TBIO
|
-6.04 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
-19.73 | - | - | $ 1.94 B | Canada |
 |
Urovant Sciences Ltd.
UROV
|
-231.84 | - | - | $ 532 M | Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-13.39 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
-49.24 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
-32.16 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
-1.14 | - | 0.10 % | $ 92.2 M | China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-54.65 | - | -7.58 % | $ 264 M | USA |
 |
Vanda Pharmaceuticals
VNDA
|
-45.1 | $ 4.17 | 2.08 % | $ 246 M | USA |
 |
Verrica Pharmaceuticals
VRCA
|
-37.98 | $ 3.88 | 10.23 % | $ 41.3 M | USA |
 |
Leap Therapeutics
LPTX
|
3.06 | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
-54.44 | $ 29.06 | -7.64 % | $ 1.5 B | Canada |
 |
Adial Pharmaceuticals
ADIL
|
-119.54 | $ 3.15 | -35.42 % | $ 2.11 M | USA |
 |
ADMA Biologics
ADMA
|
23.54 | $ 13.19 | 4.1 % | $ 3.14 B | USA |
 |
Cortexyme
CRTX
|
-89.8 | - | -1.05 % | $ 67.1 M | USA |